Muscle involvement in mixed connective tissue disease

Rheumatic Disease Clinics of North America

Volumn 31, Issue 3, 2005, Pages 509-517

  Hall, Stephen ^a,c   Hanrahan, Patrick ^b  

^a MONASH UNIVERSITY   (Australia)

^b ROYAL PERTH HOSPITAL   (Australia)

^c CABRINI INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; AZATHIOPRINE; CORTICOSTEROID; CREATINE KINASE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOGLOBULIN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RIBONUCLEOPROTEIN ANTIBODY; RIBONUCLEOPROTEIN ANTIBODY U1; TACROLIMUS; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR INHIBITOR; UNCLASSIFIED DRUG;

CLINICAL FEATURE; CLINICAL TRIAL; DERMATOMYOSITIS; DISEASE SEVERITY; FIBROMYALGIA; HISTOPATHOLOGY; HUMAN; KIDNEY FAILURE; MALIGNANT HYPERTENSION; MIXED CONNECTIVE TISSUE DISEASE; MUSCLE BIOPSY; MUSCLE DISEASE; MUSCLE WEAKNESS; MYALGIA; MYOPATHY; MYOSITIS; NEPHROTOXICITY; POLYMYOSITIS; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SCLERODERMA; SYSTEMIC LUPUS ERYTHEMATOSUS;

AUTOANTIBODIES; HUMANS; MIXED CONNECTIVE TISSUE DISEASE; MUSCULAR DISEASES; PROGNOSIS; RIBONUCLEOPROTEIN, U1 SMALL NUCLEAR;

EID: 23444433418     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2005.04.003     Document Type: Review

References (36)

1. G.C. Sharp, W.S. Irvin, and E.M. Tan Mixed connective tissue disease: an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractible nuclear antigen (ENA) Am J Med 52 1972 148 159
2. R. Kasukawa, T. Tojo, and S. Miyawaki Preliminary diagnostic criteria for classification of mixed connective tissue disease R. Kasukawa G.C. Sharp Mixed connective tissue disease and anti-nuclear antibodies 1987 Elsevier Amsterdam 41 47
3. D. Alarcon-Segovia, and M.H. Cardiel Comparison between three diagnostic criteria for mixed connective tissue disease. Study of 593 patients J Rheum 16 1989 328 334
4. G.C. Sharp, W.S. Irvin, and C.M. May Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective tissue disease, systemic lupus erythematosus and other rheumatic diseases N Engl J Med 295 1976 1150 1154
5. D. Alarcon-Segovia Mixed connective tissue disease and overlap syndromes Clin Dermatol 12 1994 309 316
6. R.C. Kitridou, M. Akmal, and S.B. Turkel Renal involvement in mixed connective tissue disease: a longitudinal clinicopathologic study Semin Arthritis Rheum 16 1986 135 145
7. J.M. Amigues, A. Cantagrel, and M. Abbal Comparative study of 4 diagnosis criteria sets for mixed connective tissue disease in patients with anti-RNP antibodies J Rheumatol 23 1996 2055 2062
8. M.A. Burdt, R.W. Hoffman, and S.L. Deutscher Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings Arthritis Rheum 42 1999 899 909
9. P. Coppo, J.P. Clauvel, and D. Bengoufa Inflammatory myositis associated with anti-U1-small nuclear ribonucleoprotein antibodies: a subset of myositis associated with a favourable outcome Rheumatol 41 2002 1040 1046
10. I. Lundberg, I. Nennesmo, and E. Hedfors A clinical, serological and histopathological study of myositis patients with and without anti-RNP antibodies Semin Arthritis Rheum 22 1992 127 138
11. C. Rivest, F.W. Miller, and L.A. Love Focal myositis presenting as pseudothrombophlebitis of the neck in a patient with mixed connective tissue disease Arthritis Rheum 39 1996 1254 1258
12. J. Martens, and M. Demedts Diaphragmatic dysfunction in mixed connective tissue disease Scand J Rheumatol 11 1982 165 167
13. M.A. Alpert, S.H. Goldberg, and B.H. Singsen Cardiovascular manifestations of mixed connective tissue disease in adults Circulation 68 1983 1182 1193
14. A.D. Lash, A.-L. Wittman, and F.P. Quismorio Myocarditis in mixed connective tissue disease: clinical and pathological study of three cases and review of the literature Semin Arthritis Rheum 15 1986 288 296
15. M.C. Dalakas, and R. Hohlfeld Polymyositis and dermatomyositis Lancet 362 2003 971 982
16. A.W. Friedman, M.B. Tewi, and C. Ahan Systemic lupus erythematosus in three ethnic groups; XV. Prevalence and correlates of fibro myalgia Lupus 12 2003 274 279
17. M. Nirmalanathan, J.L. Holton, and M.G. Hanna Is it really myositis? A consideration of the differential diagnosis Curr Opin Rheumatol 16 2004 684 691
18. J.T. Kissel, J.R. Mendell, and K.W. Rammohan Microvascular deposition of complement membrane attack complex in dermatomyositis N Engl J Med 314 1986 329 334
19. K. Arahata, and A.G. Engel Monoclonal antibody analysis of mononuclear cells in myopathies: V, identification and quantitation of T8+ cytotoxic and T8 suppressor cells Ann Neurol 23 1988 493 499
20. R. Oxenhandler, M. Hart, and L. Corman Pathology of skeletal muscle in mixed connective tissue disease Arthritis Rheum 20 1977 985 988
21. I.M. Bronner, W.H.J.P. Linssen, and M.F.G. Van der Meulen Polymyositis Arch Neurol 61 2004 132 135
22. C.L. Cooke, and H.I. Lurie Case report: fatal gastrointestinal haemorrhage in mixed connective tissue disease Arthritis Rheum 20 1977 1421 1427
23. R.M. Bennett, and D.J. O'Connell Mixed connective tissue disease: a clinicopathological study Semin Arthritis Rheum 10 1980 25 51
24. M.A.A.G. Vianna, C.T.L. Borges, and E.F. Borba Myositis in mixed connective tissue disease: a unique syndrome characterized by immunohistopathologic elements of both polymyositis and dermatomyositis Arq Neuropsiquiatr 62 2004 923 934
25. A.M. Emslie-Smith, and A.G. Engel Necrotizing myopathy with pipestem capillaries, microvascular deposition of the complement membrane attack complex (MAC) and minimal cellular infiltration Neurology 41 1991 936 939
26. S.A. Greenberg, and A.A. Amato Inflammatory myopathy associated with mixed connective tissue disease and scleroderma renal crisis Muscle Nerve 24 2001 1562 1566
27. J. De Bleecker, V. Ver Vaet, and H.P. Van den Berg Necrotizing myopathy with microvascular deposition of the complement membrane attack complex Clin Neuropathol 23 2004 76 79
28. M.F. Van der Meulen, I.M. Bronner, and J.E. Hoogendijk Polymyositis: a diagnostic entity reconsidered Neurology 61 2003 316 321
29. R. Brouwer, G.J.D. Hengtsman, and W. Vree Egberts Autoantibody profile in the sera of European patients with myositis Ann Rheum Dis 60 2001 116 123
30. I. Uthman, D. Vazquez-Abad, and J.-L. Senecal Distinctive features of idiopathic inflammatory myopathies in French Canadians Semin Arthritis Rheum 26 1996 447 458
31. A.A. Amato, and R.C. Griggs Treatment of idiopathic inflammatory myopathies Curr Opin Neurol 16 2003 569 575
32. M.C. Dalakas, I. Illa, and J.M. Dambrosia A controlled clinical trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis N Engl J Med 329 1993 1993 2000
33. R. Myllykangas-Luosujarvi, E. Jantunen, and O. Kaipiainen-Seppanen Autologous peripheral blood stem cell transplantation in a patient with severe mixed connective tissue disease Scand J Rheumatol 29 2000 326 327
34. A. Bohan, and J.B. Peter Polymyositis and dermatomyositis (first of two parts) N Engl J Med 292 1975 344 347
35. A. Bohan, and J.B. Peter Polymyositis and dermatomyositis (second of two parts) N Engl J Med 292 1975 403 407
36. R. Buchbinder, A. Forbes, and S. Hall Incidence of malignant disease in biopsy-proven inflammatory myopathy Ann Intern Med 134 2001 1087 1095